Model
Edge
RVL Pharmaceuticals
0001767593
Filing Type
3
Filing Date
8/11/2022
Updated
8/12/22, 10:05 AM
Filing
3
Earnings Release
Exhibits
3
Initial Statement of Beneficial Ownership